Neuroblastoma - Pipeline Insight, 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Neuroblastoma-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Neuroblastoma. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Neuroblastoma by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Neuroblastoma

  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Neuroblastoma

  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information

  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Neuroblastoma

  • The report also covers the dormant and discontinued pipeline projects related to the Neuroblastoma

Reasons to Buy

  • Establish comprehensive understanding of the pipeline activity across this Neuroblastoma to formulate effective R&D strategies

  • Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine

  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Neuroblastoma therapeutics

  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Neuroblastoma - Pipeline Insight, 2017

Table of Contents

1. Report Introduction

2. Neuroblastoma Overview

3. Pipeline Therapeutics
An Overview of Pipeline Products for Neuroblastoma

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Total Products for Neuroblastoma
Table 2: Products in Clinical Stage
Table 3: Products in Pre-Clinical and Discovery Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures

Figure 1:Total Products for Neuroblastoma
Figure 2: Products in Clinical Stage
Figure 3: Products in Pre-Clinical and Discovery Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
  • Global Chronic Lymphocytic Leukemia Therapeutics Market Size, Status and Forecast 2025
    Published: 09-Jan-2018        Price: US 3300 Onwards        Pages: 91
    This report studies the global Chronic Lymphocytic Leukemia Therapeutics market, analyzes and researches the Chronic Lymphocytic Leukemia Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Amgen - Abbott - Roche AG - Novartis - Johnson and Johnson - Sanofi Genzyme Corporation - Akebia Therapeutics - Celgene......
  • Global Lung Cancer Therapeutics Market Size, Status and Forecast 2025
    Published: 09-Jan-2018        Price: US 3300 Onwards        Pages: 98
    This report studies the global Lung Cancer Therapeutics market, analyzes and researches the Lung Cancer Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Roche - Merck - AstraZeneca - Sanofi-Aventis - Eli Lilly and Company - Abbott - Akebia Therapeutics - Agennix AG Market segment by Regions......
  • Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report
    Published: 05-Jan-2018        Price: US 3500 Onwards        Pages: 73
    Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market ......
  • Medulloblastoma - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 197
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma - Pipeline Review, H2 2017, provides an overview of the Medulloblastoma (Oncology) pipeline landscape. Medulloblastoma is the most common malignant brain tumor in children. Medulloblastoma by definition occur in the cerebellum, which is the part of brain located at the base of the skull, just above the brainstem. Symptoms associated with a medulloblastoma include headaches in the mo......
  • High-Grade Glioma - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 333
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma - Pipeline Review, H2 2017, provides an overview of the High-Grade Glioma (Oncology) pipeline landscape. Highly grade gliomas (HGG) are tumors of the central nervous system (CNS) that arising from transformed cells of the brain and spinal cord. Symptoms include developmental delay, headaches, backaches, nausea and vomiting, dizziness, gait disturbances, impaired vision, lack of co......
  • Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 766
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape. Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers) and weight loss. Treatment includes chemotherapy and radi......
  • Colorectal Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 1962
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H2 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation,......
  • Pancreatic Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 2270
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H2 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of......
  • Ovarian Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 2232
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H2 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs